the aid library

LIST OPTIONS

Sort by:

Direction:

Guidelines on hepatitis B and C testing
recommended

World Health Organization (WHO) (2017) C_WHO

Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei... more

Download (288)

View PDF (602)

Framework of Indicators and Targets for laboratory strengthening under the end tb strategy

World Health Organization (2016) C_WHO

Download (96)

View PDF (135)

Global guidance on criteria and process for validation: Elimination of mother-to-child transmission of HIV and Syphilis

World Health Organization; UNAIDS; UNFPA World Health Organization; UNAIDS; UNFPA (2017) C_WHO

Guidance Second Edition Monitoring and Evaluation

Download (432)

View PDF (1930)

Handbook on TB laboratory diagnostic methods in the European Union

European Centre for Disease Prevention and Control (2016) C1

The aim of this handbook is to provide network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis, ranging from microbiological diagnosis of active TB to the diagnosis of latent ... more

Download (591)

View PDF (659)

India: National Guidelines for HIV Testing

National AIDS Control Organisation (NACO), Ministry of Health & Family Welfare, Government of India (2015) C1

Download (1912)

View PDF (2800)

Philippines: Manual of Procedures of the National Tuberculosis Control Program 5th Edition
recommended

Department of Health (DOH) (2014) C1

Download (988)

View PDF (770)

Philippines: National tuberculosis control program laboratory network strategic plan 2013-2016

Noel G. Macalalad, Ma. Cecilia G. Ama, Arthur B. Lagos et al. Research Institute for Tropical Medicine National Tuberculosis Reference Laboratory (2013) C1

Download (564)

View PDF (2204)

TB in India 2017
recommended

Central TB Divison, Ministry of Health and Social Welfare, Government of India World Health Organisation (WHO) (2017) C1

Revised National TB Control Programme. Annual Status Report

Download (822)

View PDF (1436)

Worldwide country situation analysis: response to antimicrobial resistance

World Health Organization (2015) C_WHO

A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant... more

Download (295)

View PDF (336)

Sodium intake and iodized salt in the South-East Asia Region

World Health Organization (WHO), Regional Office for South-East Asia (2015) C_WHO

Report of a regional workshop, New Delhi, India, 29–30 September 2014
To reduce the burden of cardiovascular disease and its subsequent problems, the WHO Regional Office for South-East Asia organized a regional workshop on sodium intake and iodized salt for Member States in the South-East Asi... more

Download (1663)

View PDF (874)

National HIV Testing and Treatment Guidelines 2017
recommended

Nepal, Ministry of Health, National Centre for AIDS and STD Control (2017) C1

Download (154)

View PDF (147)

Putting HIV and HCV to the test - A product guide for point-of-care CD4 tests and laboratory-based and point-of-care HIV and HCV viral load tests

Medecins Sans Frontieres (Access Campaign) (2017) C2

3rd Edition – July 2017 www.msfaccess.org

Download (163)

View PDF (217)

HIV Viral load testing operational guide. 60 Lessons learned from the OPP-ERA Project

OPP-ERA, et al. Solthis, et al. (2019) C1

The Guide to operationalize HIV viral load testing HIV presents 60 lessons learnt from the project in a systemic approach including: viral load strategy, laboratories, procurement and supply management, patient care and economy.

Download (534)

View PDF (746)

Ghana Laboratory Viral Load Testing, Expansion Plan 2017-2020
recommended

Ghana Health Service (GHS) (2017) C1

Due to the anticipated significant rise in VL testing occasioned by Ghana’s adaptation of 2016 ART guidelines, it has become necessary to develop this VL scale-up and operational plan to assure complete client access to laboratory monitoring towards the achievement of the third 90 of the HIV care ... more

Download (222)

View PDF (323)

GLI Practical Guide to TB Laboratory Strengthening

Global Laboratory Initiative World Health Organization (2017) C_WHO

Download (81)

View PDF (622)

Antimicrobial resistance in Africa: a systematic review

Tilahun Tadesse, B., E. A. Ashley, S. Ongarello et al. BMC Infectious Diseases (2017) C2

Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion... more

Download (137)

View PDF (146)

WHO Worldwide country situation analysis: response to antimicrobial resistance

World Health Organization WHO (2015) C_WHO

WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga... more

Download (117)

View PDF (99)

Laboratory manual for yellow fever
recommended

World Health Organization WHO (2024) C_WHO

This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh... more

Download (12)

View PDF (11)

National Tuberculosis and Leprosy Control Strategic Plan

Government of Malawi; Ministry of Health Malawi (2024) CC2

Malawi is a landlocked country with a surface area of 118,484 km2. Administratively, the country is divided into three regions, namely the Northern, Central and Southern regions. The country has 28 districts, which are further divided into traditional authorities (TA) ruled by chiefs. The TAs are su... more

Download (7)

View PDF (6)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Guidelines on hepatitis B and C testing recommended

Philippines: Manual of Procedures of the National Tuberculosis Control Program 5th Edition recommended

TB in India 2017 recommended

National HIV Testing and Treatment Guidelines 2017 recommended

Ghana Laboratory Viral Load Testing, Expansion Plan 2017-2020 recommended

Laboratory manual for yellow fever recommended